• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Rain Enhancement Technologies Holdco Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    4/7/25 4:21:40 PM ET
    $RAIN
    Industrial Machinery/Components
    Technology
    Get the next $RAIN alert in real time by email
    false 0002028293 0002028293 2025-04-01 2025-04-01 0002028293 RAIN:ClassCommonStockParValue0.0001PerShareMember 2025-04-01 2025-04-01 0002028293 RAIN:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50Member 2025-04-01 2025-04-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

     

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): April 1, 2025

     

    RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.

    (Exact name of registrant as specified in its charter)

     

    Massachusetts   001-42460   99-3527155
    (State or other jurisdiction
    of incorporation)
      (Commission File Number)   (IRS Employer
    Identification No.)

     

    4851 Tamiami Trail N, Suite 200

    Naples, FL 34103

    (Address of principal executive offices, including zip code)

     

    Registrant’s telephone number, including area code: 339-222-6714

     

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Class A common stock, par value $0.0001 per share   RAIN   The Nasdaq Stock Market LLC
    Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50   RAINW   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

    Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

     

    On April 1, 2025, the board of directors (the “Board”) of Rain Enhancement Technologies Holdco, Inc. (the “Company”), increased the size of the Board from five to seven directors and appointed Mr. Marcus Peperzak and Mr. Robert Reardon to the Board to fill the resulting vacancies. Mr. Reardon was appointed to serve as a Class I director with a term expiring at the Company’s first annual meeting of stockholders and Mr. Peperzak was appointed to serve as a Class II director with a term expiring at the second annual meeting of stockholders. Mr. Peperzak and Mr. Reardon will serve on the Audit Committee of the Board. The Board has determined that Mr. Peperzak and Mr. Reardon are independent directors and meet the applicable standards for Audit Committee service under both the Nasdaq Stock Market Rules and Rule 10A-3 under the Securities Exchange Act of 1934.

     

    In connection with their appointments to the Board, Mr. Reardon and Mr. Peperzak each entered into Director Agreements (as defined below). The grants of restricted stock to Mr. Reardon and Mr. Peperzak pursuant to the Director Agreements were deferred by the Board. Additionally, in connection with their appointments to the Board, Mr. Peperzak and Mr. Reardon entered into an Indemnity Agreement consistent with the Company’s form of Indemnity Agreement that is filed as Exhibit 10.1 to the Company's Current Report on Form 8-K, filed with the Securities and Exchange Commission on January 7, 2025.

     

    There are no arrangements or understandings between Mr. Peperzak and Mr. Reardon and any other persons pursuant to which Mr. Peperzak and Mr. Reardon were selected as directors of the Company. There are no family relationships between Mr. Peperzak and Mr. Reardon and any of the Company’s other directors or executive officers and Mr. Peperzak and Mr. Reardon do not have any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

     

    Effective as of April 4, 2025, the Board adopted a form of Director Agreement to govern the terms of service and compensation of the Company’s non-employee directors (the “Director Agreement”). Under the Director Agreement, members of the Board will receive compensation for service on the Board and on committees of the Board consisting of the following: (i) subject to approval by the Board and compensation committee of the Board (the “Compensation Committee”), a cash payment of $12,500 promptly following attendance at each quarterly Board meeting, for a total annual cash compensation of $50,000; and (ii) at the beginning of each year of service, and subject to approval by the Board and the Compensation Committee, a grant of restricted stock, with the number of shares determined by dividing $100,000 by the closing price of the Company’s Class A common stock, par value $0.0001 per share (“Class A Common Stock”) as reported on the Nasdaq Stock Market LLC on the date of the grant. The restricted stock granted pursuant to the Director Agreement will vest in full on the first anniversary of the grant date, subject to acceleration in accordance with the terms of the restricted stock award or the Company’s 2024 Incentive Award Plan. The foregoing description of the Director Agreement does not purport to be complete and is qualified in its entirety by reference to the form of Director Agreement attached hereto as Exhibit 10.1.

     

    Additionally, effective as of April 4, 2025, the Company entered into Director Agreements with Lyman Dickerson, Alexandra Steele, and Christopher Riley, each non-employee members of the Board. The terms of the Director Agreements are consistent with the Company’s standard form of Director Agreement described above, except with respect to the grants of restricted stock to Mr. Dickerson and Mr. Riley, which are as follows: (i) subject to approval by the Board and the Compensation Committee, in lieu of an annual grant of restricted stock, Mr. Dickerson will receive an initial grant of restricted stock equal to the number of shares determined by dividing $2,000,000 by the closing price of the Class A Common Stock on the date of grant, and such grant of restricted stock will vest in full on the third anniversary of the grant date, subject to acceleration in accordance with the terms of the restricted stock award or the Company’s 2024 Incentive Award Plan, and (ii) subject to approval by the Board and the Compensation Committee, Mr. Riley will receive an annual grant of restricted stock equal to the number of shares determined by dividing $50,000 by the closing price of the Class A Common Stock on the date of grant.

     

    The grants of restricted stock to each of Mr. Dickerson, Ms. Steele and Mr. Riley pursuant to the Director Agreements were deferred by the Board.

     

    1

     

     

    Item 9.01. Financial Statements and Exhibits.

     

    (d)   Exhibits.
         
    10.1+   Form of Director Agreement.
    104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

    +Management contract or compensatory plan or arrangement.

     

    2

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Date: April 7, 2025 RAIN ENHANCEMENT TECHNOLOGIES HOLDCO, INC.
       
      By: /s/ Oanh Truong
      Name: Oanh Truong
      Title: Interim Chief Financial Officer

     

    3

    Get the next $RAIN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $RAIN

    DatePrice TargetRatingAnalyst
    5/30/2023Buy → Neutral
    ROTH MKM
    3/21/2023$11.00Outperform
    SVB Securities
    1/31/2023$21.00Buy
    ROTH Capital
    1/23/2023$18.00Buy
    Mizuho
    9/12/2022$10.00Buy
    H.C. Wainwright
    4/1/2022$15.00Outperform
    Oppenheimer
    9/14/2021$22.00Neutral
    Goldman
    7/20/2021$25.00Overweight
    Piper Sandler
    More analyst ratings

    $RAIN
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Rain Enhancement Technologies Holdco, Inc. Announces Management Updates and Appointment of Randy Seidl as Chief Executive Officer

      Technology Industry Veteran With Over 30 Years Of Enterprise Leadership Experience To Accelerate RET's Growth And Commercialization Strategy Rain Enhancement Technologies Holdco, Inc. ("RET Holdco" or the "Company") (NASDAQ:RAIN, RAINW)), an emerging company developing rainfall generation technology, today announced that Randy Seidl has been appointed as Chief Executive Officer ("CEO") of RET Holdco and of its wholly-owned subsidiary, Rain Enhancement Technologies, Inc. ("RET"). Seidl has served as Co-Chief Executive Officer and a member of the Board of Directors since January 2, 2025. Seidl brings over three decades of experience scaling technology companies and driving revenue growth.

      2/3/25 8:00:00 AM ET
      $ONDS
      $RAIN
      Radio And Television Broadcasting And Communications Equipment
      Technology
      Industrial Machinery/Components
    • Pathos AI Completes Acquisition of Rain Oncology

      Rain Stockholders to Receive $1.16 Per Share in Cash Plus Contingent Value Rights Pathos AI, Inc. ("Pathos") today announced that it has, through its wholly owned subsidiary WK Merger Sub, Inc. ("Merger Sub"), successfully completed its tender offer to acquire all outstanding shares of the common stock of Rain Oncology Inc. (NASDAQ:RAIN) ("Rain") for $1.16 per share in cash plus one contingent value right per share (each, a "CVR"), which CVR shall represent the right to receive potential payments pursuant to the terms and subject to the conditions of the Contingent Value Rights Agreement, dated as of January 26, 2024, by and among Pathos, Merger Sub, Equiniti Trust Company, LLC, and Forti

      1/26/24 8:49:00 AM ET
      $RAIN
      Industrial Machinery/Components
      Technology
    • Rain Oncology Enters into Agreement to be Acquired by Pathos AI for $1.16 in Cash per Share Plus Contingent Value Rights

      NEWARK, Calif., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Rain Oncology Inc. (NASDAQ:RAIN) ("Rain"), today announced it has entered into a definitive merger agreement whereby Pathos AI, Inc. ("Pathos") will acquire Rain for $1.16 in cash per share plus a non-tradeable contingent value right (a "CVR") for potential cash payments of up to approximately $0.17 per share. The Rain Board of Directors voted unanimously to approve the proposed Offer, Merger and related transactions contemplated by the Merger Agreement (collectively, the "Transaction"). The upfront cash consideration represents a 17% premium over Rain's unaffected stock price as of October 13, 2023. The Rain Board reached this determinati

      12/13/23 6:05:30 PM ET
      $RAIN
      Industrial Machinery/Components
      Technology

    $RAIN
    SEC Filings

    See more
    • SEC Form EFFECT filed by Rain Enhancement Technologies Holdco Inc.

      EFFECT - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Filer)

      4/28/25 12:15:05 AM ET
      $RAIN
      Industrial Machinery/Components
      Technology
    • SEC Form 424B3 filed by Rain Enhancement Technologies Holdco Inc.

      424B3 - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Filer)

      4/25/25 4:20:34 PM ET
      $RAIN
      Industrial Machinery/Components
      Technology
    • SEC Form POS AM filed by Rain Enhancement Technologies Holdco Inc.

      POS AM - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Filer)

      4/17/25 9:51:47 PM ET
      $RAIN
      Industrial Machinery/Components
      Technology

    $RAIN
    Leadership Updates

    Live Leadership Updates

    See more
    • Rain Enhancement Technologies Holdco, Inc. Announces Management Updates and Appointment of Randy Seidl as Chief Executive Officer

      Technology Industry Veteran With Over 30 Years Of Enterprise Leadership Experience To Accelerate RET's Growth And Commercialization Strategy Rain Enhancement Technologies Holdco, Inc. ("RET Holdco" or the "Company") (NASDAQ:RAIN, RAINW)), an emerging company developing rainfall generation technology, today announced that Randy Seidl has been appointed as Chief Executive Officer ("CEO") of RET Holdco and of its wholly-owned subsidiary, Rain Enhancement Technologies, Inc. ("RET"). Seidl has served as Co-Chief Executive Officer and a member of the Board of Directors since January 2, 2025. Seidl brings over three decades of experience scaling technology companies and driving revenue growth.

      2/3/25 8:00:00 AM ET
      $ONDS
      $RAIN
      Radio And Television Broadcasting And Communications Equipment
      Technology
      Industrial Machinery/Components

    $RAIN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Dacier Paul T bought $150,040 worth of shares (13,173 units at $11.39) (SEC Form 4)

      4 - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Issuer)

      2/10/25 4:54:42 PM ET
      $RAIN
      Industrial Machinery/Components
      Technology
    • Large owner Dacier Paul T bought $100,027 worth of shares (8,782 units at $11.39) (SEC Form 4)

      4 - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Issuer)

      12/31/24 7:50:27 PM ET
      $RAIN
      Industrial Machinery/Components
      Technology
    • Tang Kevin C bought $279,030 worth of shares (284,145 units at $0.98) (SEC Form 4)

      4 - Rain Oncology Inc. (0001724979) (Issuer)

      10/13/23 4:57:52 PM ET
      $RAIN
      Industrial Machinery/Components
      Technology

    $RAIN
    Financials

    Live finance-specific insights

    See more

    $RAIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more

    $RAIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Rain Oncology Reports Second Quarter 2023 Financial Results and Provides Corporate Update

      – Evaluating a number of opportunities to diversify pipeline in precision oncology – – Submitted data abstracts for milademetan in both MANTRA and MANTRA-2 clinical studies; anticipated presentations at medical conferences in 4Q23 – – Quarter-end cash position of $86.3 million expected to provide runway into year-end 2026 – – Management to host conference call and webcast today at 2:00 pm PT/5:00 pm ET – NEWARK, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Rain Oncology Inc. (NASDAQ:RAIN), (Rain), today reports financial results for the second quarter ended June 30, 2023, and provides a corporate update. "Rain has been aggressively pursuing a multitude of opportunities as we seek to leve

      8/10/23 4:05:00 PM ET
      $RAIN
      Industrial Machinery/Components
      Technology
    • Rain Oncology to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 10, 2023

      NEWARK, Calif., July 26, 2023 (GLOBE NEWSWIRE) -- Rain Oncology Inc. (NASDAQ:RAIN), ("Rain") today announced it will report financial results for the second quarter ended June 30, 2023 and provide a corporate update on Thursday, August 10, 2023. On that day, management will host a conference call and webcast at 2:00 pm PT (5:00 pm ET) to discuss the Company's business and financial results. Conference Call and Webcast Details: Date: August 10, 2023Time: 2:00 pm PT (5:00 pm ET)Dial In Numbers: 1 (888) 886-7786 (U.S. Toll Free) / 1 (416) 764-8658 (International)Conference ID: 29873479Webcast Link: https://viavid.webcasts.com/starthere.jsp?ei=1624922&tp_key=7933f8175f A replay of the ca

      7/26/23 8:00:00 AM ET
      $RAIN
      Industrial Machinery/Components
      Technology
    • Rain Oncology Announces Topline Results from Phase 3 MANTRA Trial of Milademetan for the Treatment of Dedifferentiated Liposarcoma

      – The Phase 3 MANTRA trial did not meet the primary endpoint of progression free survival vs. standard of care – – The median PFS was 3.6 months for milademetan versus 2.2 months for trabectedin with a hazard ratio of 0.89 – – Rain to host a conference call at 8:30 a.m. ET – NEWARK, Calif., May 22, 2023 (GLOBE NEWSWIRE) -- Rain Oncology Inc. (NASDAQ:RAIN), (Rain), a late-stage company developing precision oncology therapeutics with its lead product candidate, milademetan, an oral, small molecule inhibitor of the MDM2-p53 complex that reactivates p53, today announced its topline pivotal Phase 3 MANTRA data. The trial, evaluating the efficacy, safety, and tolerability of milademetan in p

      5/22/23 8:00:00 AM ET
      $RAIN
      Industrial Machinery/Components
      Technology
    • SEC Form SC 13G/A filed by Rain Oncology Inc. (Amendment)

      SC 13G/A - Rain Oncology Inc. (0001724979) (Subject)

      2/14/24 5:14:27 PM ET
      $RAIN
      Industrial Machinery/Components
      Technology
    • SEC Form SC 13G/A filed by Rain Oncology Inc. (Amendment)

      SC 13G/A - Rain Oncology Inc. (0001724979) (Subject)

      2/14/24 4:19:28 PM ET
      $RAIN
      Industrial Machinery/Components
      Technology
    • SEC Form SC 13G/A filed by Rain Oncology Inc. (Amendment)

      SC 13G/A - Rain Oncology Inc. (0001724979) (Subject)

      2/7/24 7:45:02 AM ET
      $RAIN
      Industrial Machinery/Components
      Technology
    • Rain Oncology downgraded by ROTH MKM

      ROTH MKM downgraded Rain Oncology from Buy to Neutral

      5/30/23 10:27:43 AM ET
      $RAIN
      Industrial Machinery/Components
      Technology
    • SVB Securities initiated coverage on Rain Oncology with a new price target

      SVB Securities initiated coverage of Rain Oncology with a rating of Outperform and set a new price target of $11.00

      3/21/23 8:58:11 AM ET
      $RAIN
      Industrial Machinery/Components
      Technology
    • ROTH Capital resumed coverage on Rain Oncology with a new price target

      ROTH Capital resumed coverage of Rain Oncology with a rating of Buy and set a new price target of $21.00

      1/31/23 9:10:39 AM ET
      $RAIN
      Industrial Machinery/Components
      Technology

    $RAIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Reardon Robert

      3 - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Issuer)

      4/18/25 4:30:40 PM ET
      $RAIN
      Industrial Machinery/Components
      Technology
    • SEC Form 3 filed by new insider Peperzak Marcus

      3 - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Issuer)

      4/11/25 4:01:05 PM ET
      $RAIN
      Industrial Machinery/Components
      Technology
    • Large owner Dacier Paul T bought $150,040 worth of shares (13,173 units at $11.39) (SEC Form 4)

      4 - Rain Enhancement Technologies Holdco, Inc. (0002028293) (Issuer)

      2/10/25 4:54:42 PM ET
      $RAIN
      Industrial Machinery/Components
      Technology